Wednesday, February 10, 2010, 12:59PM AEST - The Australian Stockmarket closes in 3 hours and 6 minutes.
To create a watchlist or portfolio of shares, Register

Antares Pharma Inc. (AIS)

8:00AM AEST: 1.12 USD  Up 0.0001 (0.01%)  
 MORE ON AIS 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 ANTARES PHARMA INC (AMEX:AIS) Delayed quote dataEdit
Last Trade:1.12 USD
Trade Time: 8:00AM AEST
Change:Up 0.0001 (0.01%)
Prev Close:1.1199
Open:1.15
Bid:N/A
Ask:N/A
1y Target Est:2.50
Day's Range:1.10 - 1.15
52wk Range:0.30 - 1.35
Volume:140,268
Avg Vol (3m):327,119
Market Cap:91.52M
P/E (ttm):N/A
EPS (ttm):-0.152
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add AIS to Portfolio   Download Data

 HEADLINES 
Skymark Research Initiates Independent Research Coverage on Antares Pharma, Inc.
GlobeNewswire (Thu, Feb 4)
ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES' Patient-Friendly Injector for Growth Hormone Deficiency in Children
Business Wire (Wed, Feb 3)
Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Business Wire (Thu, Jan 21)
Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
Business Wire (Tue, Jan 12)
Coverage initiated on Antares Pharma by Roth Capital
Briefing.com (Fri, Jan 8)
Prospecting for Stocks: Antares Pharma
at Motley Fool (Tue, Dec 29)
ANTARES PHARMA, INC. Financials
EDGAR Online Financials (Wed, Nov 18)
ANTARES PHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Fri, Nov 13)
Antares Pharma, Inc. Earnings Call scheduled for 4:30 pm ET today
CCBN (Tue, Nov 10)
ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
EDGAR Online (Tue, Nov 10)
More Headlines for AIS...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.14
EPS Est (in 2 years) (Dec-10) :-0.07
Avg Rec (current)*:1.7
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Antares Pharma, Inc. operates as a specialty drug delivery/pharmaceutical company. Its drug delivery platforms include Advanced Transdermal Delivery gels, disposable pressure assisted auto injection systems, reusable needle-free injection systems,...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices